IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY RATES IN PATENTS WITH ISCHEMIC CARDIOMYOPATHY SELECTED FOR PRIMARY PREVENTION DEVICES ON THE BASIS OF LEFT VENTRICULAR EJECTION FRACTION AND ELECTROPHYSIOLOGY TESTING

2014 ◽  
Vol 30 (10) ◽  
pp. S323
Author(s):  
W.F. McIntyre ◽  
M. Golian ◽  
M. Zahrani ◽  
A. Khadem
Sign in / Sign up

Export Citation Format

Share Document